Market Capitalization & Enterprise Value
Research-grade valuation history for JBIO. Track market capitalization versus enterprise value to see the impact of net debt and share changes. Use the interactive chart to explore different horizons; the table updates accordingly to support auditability and export.
Market Cap & Enterprise Value
Comparison of market capitalization and enterprise value over time
Market Cap
Enterprise Value
Market Cap History
Investor Valuation Insights
As of Mar 31, 2026EV/EBITDA
-18.77x
Negative EV/EBITDA usually means negative EBITDA; compare with revenue and cash flow metrics.
EV vs Market Cap Spread
-87.71M
EV is -18.1% vs equity value
Capital Structure Signal
Net Cash Profile
EV premium trend: -17.3 pp vs earliest data
Additional Multiples
EV/Sales: 0.00x
Net Debt/EBITDA: 1.35x
Share count change in dataset: +4396.44%
Interpretation guide: EV/EBITDA compares total firm value (debt + equity - cash) to operating earnings. Lower is usually cheaper, but always benchmark against peers, growth rate, margins, and cyclicality.
Market Cap & Enterprise Value Data
Free users can view the latest 3 records. Upgrade to see full history.
| Date | Market Cap | Enterprise Value | Stock Price | Shares |
|---|---|---|---|---|
| Dec 31, 2025 | 483.88M | 396.17M | $15.43 | 31.36M |
| Dec 31, 2024 | 75.74M | 42.41M | $92.75 | 816.63K |
| Dec 31, 2023 | 595.88M | 573.07M | $792.05 | 752.33K |
Dec 31, 2022 | — | — | — | — |
Dec 31, 2021 | — | — | — | — |
Dec 31, 2020 | — | — | — | — |